Drug intelligence / Profile preview

Zymen

Development stage: Unknown
Lead developer: Ankh Pharmaceuticals
Administration: Oral

Overview

Zymen is a branded herbal supplement developed and marketed by Ankh Pharmaceuticals. It is part of a portfolio of Ayurvedic-inspired consumer products designed for general wellness. Specifically, Zymen is indicated for digestive support and is sold as a dietary supplement rather than a regulated pharmaceutical drug. It does not have a specific molecular target or clinical development phase associated with traditional drug discovery, and is instead positioned as a branded herbal consumer product for the management of digestion.

Brand names: Zymen
Other names: Zymen

Beyond the preview

Go deeper on Zymen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zymen.

Explore the full profile